ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $16,906 | -81.2% | 12,340 | -67.6% | 0.00% | – |
Q1 2023 | $89,940 | +83.6% | 38,110 | +90.6% | 0.00% | – |
Q2 2022 | $49,000 | -29.0% | 20,000 | +14.3% | 0.00% | – |
Q1 2022 | $69,000 | +53.3% | 17,500 | +72.0% | 0.00% | – |
Q4 2021 | $45,000 | -43.8% | 10,174 | -21.1% | 0.00% | – |
Q3 2021 | $80,000 | -70.1% | 12,900 | -48.5% | 0.00% | – |
Q1 2021 | $268,000 | – | 25,062 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
CM Management, LLC | 75,000 | $593,000 | 0.43% |
Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |